Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aprea Therapeutics Inc (APRE)

Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aprea Therapeutics Inc 3805 Old Easton Road DOYLESTOWN PA 18902 USA

www.aprea.com Employees: 8 P: 215-948-4119

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Aprea Therapeutics Inc. is a biopharmaceutical company. It is focused on developing and commercializing novel cancer therapeutics which reactivate the mutant tumor suppressor protein, p53. The Company's lead drug candidate, APR-246, a first-in-class small molecule p53 reactivator, is in clinical development for myelodysplastic syndromes, acute myeloid leukemia as well as additional hematologic and solid tumor malignancies. Aprea Therapeutics Inc. is based in Boston, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 6,224
Enterprise Value, $K -16,626
Shares Outstanding, K 6,994
Annual Sales, $ 1,500 K
Annual Net Income, $ -12,960 K
Last Quarter Sales, $ 120 K
Last Quarter Net Income, $ -3,240 K
EBIT, $ -14,810 K
EBITDA, $ -14,790 K
60-Month Beta 1.23
% of Insider Shareholders 13.63%
% of Institutional Shareholders 34.19%
Float, K 6,041
% Float 86.37%
Short Interest 35
Short Float 0.49%
Short Volume Ratio 0.05

Growth:

1-Year Return -75.49%
3-Year Return -90.64%
5-Year Return -99.16%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 97.48%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.47 on 11/12/25
Next Earnings Date 03/24/26
Earnings Per Share ttm -2.32
EPS Growth vs. Prev Qtr 11.32%
EPS Growth vs. Prev Year 26.56%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 02/13/23

APRE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -88.12%
Return-on-Assets % -68.78%
Profit Margin % -864.00%
Debt/Equity 0.00
Price/Sales 4.28
Price/Cash Flow N/A
Price/Book 0.49
Book Value/Share 2.42
Interest Coverage -1.01
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar